Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kazufumi, Takamatsu"'
Autor:
Tsukie Kin Tsukuda, Hiroshi Ohnishi, Minoru Fujimoto, Yu Nakatani, Kazufumi Takamatsu, Tetsuji Naka, Akihito Yokoyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Progressive fibrosing interstitial lung diseases (PF-ILDs) have a poor prognosis and may be resistant to corticosteroids and/or immunosuppressants, but antifibrotic therapies such as nintedanib and pirfenidone have been shown to slow the det
Externí odkaz:
https://doaj.org/article/c29e9a66f1ee48548423727a2267ec30
Autor:
Fumiya Ogasawara, Shohei Yoshida, Mayuka Yamane, Kazufumi Takamatsu, Yu Arakawa, Yoshie Nishida, Megumi Komatsu, Akihito Yokoyama, Yuka Yamagishi, Kensuke Kojima
Publikováno v:
Internal Medicine. 62:1265-1271
Autor:
TETSUYA KUBOTA, MIZU SAKAI, KAZUKI ANABUKI, KAZUFUMI TAKAMATSU, KENICHI MUKAIDA, KANA KOBAYASHI, TAKUJI YAMAGAMI, AKIHITO YOKOYAMA
Publikováno v:
In Vivo; Jan/Feb2024, Vol. 38 Issue 1, p259-263, 5p
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 50, Iss 4, Pp 541-544 (2017)
We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to n
Externí odkaz:
https://doaj.org/article/a89051da305e4b5a8c4e4b678864432b
Autor:
Tsukie Kin, Tsukuda, Hiroshi, Ohnishi, Minoru, Fujimoto, Yu, Nakatani, Kazufumi, Takamatsu, Tetsuji, Naka, Akihito, Yokoyama
Publikováno v:
Scientific reports. 12(1)
Progressive fibrosing interstitial lung diseases (PF-ILDs) have a poor prognosis and may be resistant to corticosteroids and/or immunosuppressants, but antifibrotic therapies such as nintedanib and pirfenidone have been shown to slow the deterioratio
Autor:
Tsukie Kin Tsukuda, Minoru Fujimoto, Hiroshi Ohnishi, Yu Nakatani, Kazufumi Takamatsu, Tetsuji Naka, Akihito Yokoyama
Background:Progressive fibrosing interstitial lung diseases have a poor prognosis and may be resistant to corticosteroids and/or immunosuppressants, but antifibrotic therapies such as nintedanib and pirfenidone have been shown to slow the deteriorati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a71269f7d93888c476e0e2fbabb038d5
https://doi.org/10.21203/rs.3.rs-1271280/v1
https://doi.org/10.21203/rs.3.rs-1271280/v1
Autor:
Masato Yagita, Reina Takashima, Kazufumi Takamatsu, Yutaka Shinkawa, Masaaki Fujita, Motonari Fukui
Publikováno v:
Internal Medicine
Dermatomyositis is associated with various types of malignancy. However, the association of dermatomyositis with lung neuroendocrine carcinoma is rare. We herein report a case of dermatomyositis with lung neuroendocrine carcinoma.
Publikováno v:
Internal Medicine
Publikováno v:
B44. COPD: TREATMENT AND OTHER TOPICS.
Patients with chronic obstructive pulmonary disease (COPD) have several comorbidities. Leukoaraiosis (LA) is an abnormal appearance of brain white matter on neuroimaging, and it has been linked to microangiopathy of the brain. In this study, we explo
Autor:
Masaya Takemura, Ryo Itotani, Kazufumi Takamatsu, Manabu Ishitoko, Daiki Inoue, Motonari Fukui, Minoru Sakuramoto
Publikováno v:
Respiratory Investigation. 54:320-326
Background Asthma and rhinitis are common diseases that often occur concomitantly. However, in patients with asthma, the concurrent assessment of seasonal variation in rhinitis and asthma symptoms has not been comprehensively addressed. We prospectiv